Morgan Stanley Stock Performance
Morgan Stanley shares have experienced notable downward pressure across multiple timeframes, trading at $190.97 per SID market data. The stock has declined 12.42% over the past month and 14.34% over the trailing three months, though it retains a modest 5.80% gain on a one-year basis. MS currently trades below both key moving averages, sitting 8.60% beneath its 50-day moving average of $208.95 and just 0.67% below its 200-day moving average of $192.26, per Massive/Polygon data. The 14-day relative strength index has fallen to 23.2, placing the stock firmly in oversold territory and signaling potentially exhausted selling momentum. With a beta of 1.215, Morgan Stanley exhibits above-average sensitivity to broader market movements. Average daily trading volume stands at approximately 5.70 million shares, and the firm carries a market capitalization of roughly $286.34 billion.
Morgan Stanley Valuation Analysis
Morgan Stanley's current valuation metrics position the financial services giant at a price-to-earnings ratio of 17.50, according to SID market data. The PEG ratio stands at 1.70, suggesting the stock is trading at a moderate premium relative to its expected earnings growth trajectory. The price-to-book ratio registers at 2.57, reflecting the market's willingness to pay more than two and a half times book value for the firm's assets, a level consistent with large-cap diversified financial institutions. Per SEC filings, Morgan Stanley maintains a dividend yield of approximately 2.14%, providing shareholders with a steady income component. Within the broader Financial Services sector, these metrics indicate a balanced valuation profile, with the P/E ratio reflecting neither deep discount nor significant overvaluation. The combination of a sub-20 earnings multiple and above-2% dividend yield presents a fundamental picture anchored in the company's recurring revenue streams and capital return program.
Smart Money Activity for MS
Morgan Stanley's composite smart money score stands at 49 out of 100, reflecting a neutral overall signal per SID market data. Institutional positioning represents the strongest component, scoring a perfect 25 out of 25, indicating robust ownership and sustained conviction among large fund managers as documented in 13F institutional filings. Congressional trading activity scores a notable 15.6 out of 25, suggesting above-average legislative interest in the stock. In contrast, dark pool activity registers at a relatively subdued 8.9 out of 25. Insider activity scores 0.0 out of 25, the lowest possible reading, driven by uniformly bearish insider behavior. According to SEC Form 4 filings, corporate insiders executed 8 transactions over the past 90 days, all of which were sales with zero purchases recorded during the period. This consistent insider selling pattern stands in stark contrast to the strong institutional holding conviction, creating a divergent signal within the smart money framework that warrants close monitoring by investors tracking executive sentiment alongside fund positioning.
Morgan Stanley Earnings Outlook
Morgan Stanley has demonstrated a consistent pattern of exceeding Wall Street expectations in its most recent quarterly results, according to company earnings reports. In the April 2026 reporting period, the firm posted earnings of $3.43 per share against a consensus estimate of $3.04, delivering a positive surprise of $0.39 or approximately 12.8%. The July 2026 quarter showed even stronger outperformance, with actual earnings of $3.46 per share versus the $2.81 estimate, representing a $0.65 beat or roughly 23.1%. Looking ahead, analyst estimates project earnings of $2.95 per share for the upcoming April 2026 report and $3.00 per share for the October 2026 quarter. The sequential improvement in earnings surprises across the two reported quarters suggests strengthening operational momentum. These consecutive beats reflect robust performance across Morgan Stanley's diversified business segments, positioning the firm favorably heading into future reporting periods.
Wall Street Analyst Ratings for MS
Recent Wall Street analyst coverage of Morgan Stanley reflects a moderately constructive consensus, per SID consensus data. In early October 2026, BMO Capital reiterated its Outperform rating, while UBS maintained its Buy recommendation, both signaling continued confidence in the firm's fundamental trajectory. Evercore ISI Group also upheld its Outperform stance on October 1, 2026, reinforcing the bullish tilt among coverage analysts. On the more cautious side, Citigroup reiterated its Neutral rating on September 30, 2026, and HSBC maintained its Hold rating on September 28, 2026, according to Wall Street analyst reports. Of the five most recent ratings actions, three carry bullish designations — two Outperform and one Buy — while two maintain neutral stances. Notably, none of the recent ratings reflect downgrades, with all five representing reiterations of prior positions. This stability in analyst sentiment suggests that despite the stock's recent 14.34% three-month decline, fundamental coverage views have not deteriorated, with the majority maintaining positive outlooks.